

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | formation of translation preinitiation complex (GO:0001731) | 3.23852349 |
| 2 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.23233399 |
| 3 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.20046184 |
| 4 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.13187759 |
| 5 | immunoglobulin mediated immune response (GO:0016064) | 3.06457042 |
| 6 | mitotic sister chromatid cohesion (GO:0007064) | 2.85761713 |
| 7 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.81244675 |
| 8 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.77783025 |
| 9 | pentose-phosphate shunt (GO:0006098) | 2.77534070 |
| 10 | N-acetylneuraminate metabolic process (GO:0006054) | 2.75788070 |
| 11 | mitotic nuclear envelope reassembly (GO:0007084) | 2.74279127 |
| 12 | nuclear envelope reassembly (GO:0031468) | 2.74279127 |
| 13 | interferon-gamma secretion (GO:0072643) | 2.72439265 |
| 14 | B cell mediated immunity (GO:0019724) | 2.71072727 |
| 15 | trophectodermal cell differentiation (GO:0001829) | 2.66724224 |
| 16 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.66296338 |
| 17 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.66019676 |
| 18 | NADPH regeneration (GO:0006740) | 2.61027455 |
| 19 | ribosome assembly (GO:0042255) | 2.60815700 |
| 20 | amyloid precursor protein catabolic process (GO:0042987) | 2.60387482 |
| 21 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.58149222 |
| 22 | purine ribonucleotide transport (GO:0015868) | 2.55967633 |
| 23 | deoxyribose phosphate catabolic process (GO:0046386) | 2.55860046 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55383858 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 2.55383858 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55383858 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 2.55383858 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55383858 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55383858 |
| 30 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53393487 |
| 31 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.51055790 |
| 32 | regulation of mitochondrial translation (GO:0070129) | 2.48631797 |
| 33 | pentose metabolic process (GO:0019321) | 2.45924700 |
| 34 | ribosomal small subunit assembly (GO:0000028) | 2.45033487 |
| 35 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.44298564 |
| 36 | deoxyribonucleotide catabolic process (GO:0009264) | 2.43251813 |
| 37 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.42765174 |
| 38 | positive regulation of translational initiation (GO:0045948) | 2.42069336 |
| 39 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.41367179 |
| 40 | adenine nucleotide transport (GO:0051503) | 2.39942547 |
| 41 | biotin metabolic process (GO:0006768) | 2.39526498 |
| 42 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.39298990 |
| 43 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.37015271 |
| 44 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.36122829 |
| 45 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.35003272 |
| 46 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.35003272 |
| 47 | regulation of chemokine biosynthetic process (GO:0045073) | 2.32146986 |
| 48 | response to peptidoglycan (GO:0032494) | 2.31424011 |
| 49 | GDP-mannose metabolic process (GO:0019673) | 2.31387769 |
| 50 | regulation of interferon-alpha production (GO:0032647) | 2.30859020 |
| 51 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.30624472 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.29843980 |
| 53 | rRNA transcription (GO:0009303) | 2.28511274 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.28348986 |
| 55 | dosage compensation (GO:0007549) | 2.27634063 |
| 56 | regulation of early endosome to late endosome transport (GO:2000641) | 2.26653308 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 2.26468981 |
| 58 | ribosomal small subunit biogenesis (GO:0042274) | 2.25510585 |
| 59 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.24460866 |
| 60 | positive regulation of interferon-beta production (GO:0032728) | 2.23793356 |
| 61 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.23541531 |
| 62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.23519309 |
| 63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22901244 |
| 64 | rRNA modification (GO:0000154) | 2.19791454 |
| 65 | positive regulation of T cell apoptotic process (GO:0070234) | 2.19489070 |
| 66 | glucose catabolic process (GO:0006007) | 2.19449286 |
| 67 | Golgi transport vesicle coating (GO:0048200) | 2.18922812 |
| 68 | COPI coating of Golgi vesicle (GO:0048205) | 2.18922812 |
| 69 | vagina development (GO:0060068) | 2.16590633 |
| 70 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.15239370 |
| 71 | histone H2B ubiquitination (GO:0033523) | 2.14292044 |
| 72 | COPII vesicle coating (GO:0048208) | 2.13979296 |
| 73 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.13092454 |
| 74 | DNA replication initiation (GO:0006270) | 2.12876847 |
| 75 | negative regulation of type I interferon production (GO:0032480) | 2.12120201 |
| 76 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.11545594 |
| 77 | ncRNA 3-end processing (GO:0043628) | 2.11356937 |
| 78 | viral mRNA export from host cell nucleus (GO:0046784) | 2.11191810 |
| 79 | negative regulation of ligase activity (GO:0051352) | 2.10397308 |
| 80 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.10397308 |
| 81 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.09285928 |
| 82 | hepatocyte apoptotic process (GO:0097284) | 2.08156621 |
| 83 | virion assembly (GO:0019068) | 2.07635065 |
| 84 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.05294958 |
| 85 | response to hydroperoxide (GO:0033194) | 2.05276210 |
| 86 | DNA strand elongation (GO:0022616) | 2.05243424 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.05243347 |
| 88 | cellular response to arsenic-containing substance (GO:0071243) | 2.04345608 |
| 89 | nitric oxide biosynthetic process (GO:0006809) | 2.04321522 |
| 90 | mitotic metaphase plate congression (GO:0007080) | 2.02803509 |
| 91 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.02624114 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.02366220 |
| 93 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.02276184 |
| 94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.02121847 |
| 95 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.01692159 |
| 96 | regulation of translational initiation (GO:0006446) | 2.00395701 |
| 97 | intracellular lipid transport (GO:0032365) | 2.00318939 |
| 98 | DNA unwinding involved in DNA replication (GO:0006268) | 1.99561263 |
| 99 | regulation of interferon-beta biosynthetic process (GO:0045357) | 1.99537914 |
| 100 | regulation of interferon-beta production (GO:0032648) | 1.99322414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.91067511 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.74558967 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.60001702 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27017204 |
| 5 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.18296355 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17156325 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16385124 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.16207118 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13973848 |
| 10 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.97320408 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96808892 |
| 12 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.95904717 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.93649621 |
| 14 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92691128 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 1.86551895 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.84300511 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.82672987 |
| 18 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.81744222 |
| 19 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.80540705 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79137785 |
| 21 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.78398342 |
| 22 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76305286 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73627772 |
| 24 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.73514745 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71957349 |
| 26 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68140318 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66815994 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.66797409 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.66780022 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66765075 |
| 31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.64942452 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63340697 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61646018 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.61283404 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58621182 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55975535 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.53849976 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53635486 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51884885 |
| 40 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.51797806 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.51378318 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51333095 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.49898297 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45536503 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44258999 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43346229 |
| 47 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.40593616 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.39605411 |
| 49 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.38543157 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38385763 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.37558872 |
| 52 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37461635 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36829476 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36751411 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36054334 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34199391 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33999577 |
| 58 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33606482 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33333310 |
| 60 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.33327675 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32995224 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.32353510 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.32034130 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31664699 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29594287 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28728746 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28160374 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25950633 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25924067 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25841023 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25760254 |
| 72 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25513021 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25391065 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25377909 |
| 75 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.24895491 |
| 76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23801820 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21630141 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19631534 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19399625 |
| 80 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19125331 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16499729 |
| 82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16264616 |
| 83 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.15281793 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13626919 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12410067 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12203244 |
| 87 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11868752 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09571148 |
| 89 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08194374 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05695760 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05421688 |
| 92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05338765 |
| 93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04255451 |
| 94 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.01616836 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00749449 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00347450 |
| 97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00190084 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99671272 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99110106 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97680755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.59740658 |
| 2 | MP0005075_abnormal_melanosome_morpholog | 3.17033234 |
| 3 | MP0009840_abnormal_foam_cell | 3.16061766 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.72700260 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.58021737 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.55381332 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.41659176 |
| 8 | MP0003123_paternal_imprinting | 2.38760921 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.25836900 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.11736717 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.11351784 |
| 12 | MP0002796_impaired_skin_barrier | 2.04135278 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.00776669 |
| 14 | MP0005451_abnormal_body_composition | 1.94122672 |
| 15 | MP0001727_abnormal_embryo_implantation | 1.90664720 |
| 16 | MP0003111_abnormal_nucleus_morphology | 1.89146532 |
| 17 | MP0003186_abnormal_redox_activity | 1.76535200 |
| 18 | MP0003303_peritoneal_inflammation | 1.70302428 |
| 19 | MP0005076_abnormal_cell_differentiation | 1.67760383 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.67143998 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.66369139 |
| 22 | MP0003077_abnormal_cell_cycle | 1.60026891 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.58108351 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.55297830 |
| 25 | MP0010307_abnormal_tumor_latency | 1.51670732 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.48940070 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.48877783 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.39809068 |
| 29 | MP0009697_abnormal_copulation | 1.38362439 |
| 30 | MP0005501_abnormal_skin_physiology | 1.36830981 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.36232820 |
| 32 | MP0003724_increased_susceptibility_to | 1.35848185 |
| 33 | MP0002009_preneoplasia | 1.35590549 |
| 34 | MP0000490_abnormal_crypts_of | 1.34532204 |
| 35 | MP0004381_abnormal_hair_follicle | 1.33791151 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.33173913 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.31820079 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.30344607 |
| 39 | MP0001730_embryonic_growth_arrest | 1.24086041 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.23638898 |
| 41 | MP0001881_abnormal_mammary_gland | 1.22378662 |
| 42 | MP0008004_abnormal_stomach_pH | 1.19967491 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.19202781 |
| 44 | MP0009785_altered_susceptibility_to | 1.18934944 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.16254814 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.14331779 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.14016265 |
| 48 | MP0000371_diluted_coat_color | 1.13080454 |
| 49 | MP0008058_abnormal_DNA_repair | 1.12968960 |
| 50 | MP0008877_abnormal_DNA_methylation | 1.12546908 |
| 51 | MP0005025_abnormal_response_to | 1.11615973 |
| 52 | MP0001800_abnormal_humoral_immune | 1.11594547 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 1.10257523 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.09862850 |
| 55 | MP0000627_abnormal_mammary_gland | 1.09247112 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.07792242 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.07402055 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.06174912 |
| 59 | MP0002398_abnormal_bone_marrow | 1.05007563 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.03409012 |
| 61 | MP0001819_abnormal_immune_cell | 1.03128167 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.01984012 |
| 63 | MP0003436_decreased_susceptibility_to | 1.01657750 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.01553566 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.01239678 |
| 66 | MP0000462_abnormal_digestive_system | 1.00877347 |
| 67 | MP0009672_abnormal_birth_weight | 1.00494139 |
| 68 | MP0002722_abnormal_immune_system | 1.00056959 |
| 69 | MP0000358_abnormal_cell_content/ | 0.99781631 |
| 70 | MP0004947_skin_inflammation | 0.99250502 |
| 71 | MP0002723_abnormal_immune_serum | 0.98747469 |
| 72 | MP0000350_abnormal_cell_proliferation | 0.97923459 |
| 73 | MP0002419_abnormal_innate_immunity | 0.97472690 |
| 74 | MP0000313_abnormal_cell_death | 0.96915103 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.96307770 |
| 76 | MP0001873_stomach_inflammation | 0.95643196 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.95324978 |
| 78 | MP0010155_abnormal_intestine_physiology | 0.94450998 |
| 79 | MP0001764_abnormal_homeostasis | 0.93946057 |
| 80 | MP0005387_immune_system_phenotype | 0.90847354 |
| 81 | MP0001790_abnormal_immune_system | 0.90847354 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.90564929 |
| 83 | MP0000716_abnormal_immune_system | 0.90292598 |
| 84 | MP0002429_abnormal_blood_cell | 0.89448254 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.88100579 |
| 86 | MP0004233_abnormal_muscle_weight | 0.88100277 |
| 87 | MP0001853_heart_inflammation | 0.86515808 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.86400605 |
| 89 | MP0005647_abnormal_sex_gland | 0.85079375 |
| 90 | MP0000598_abnormal_liver_morphology | 0.83593371 |
| 91 | MP0008469_abnormal_protein_level | 0.83213250 |
| 92 | MP0000609_abnormal_liver_physiology | 0.83123663 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.82995742 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.82726213 |
| 95 | MP0004147_increased_porphyrin_level | 0.82366971 |
| 96 | MP0003866_abnormal_defecation | 0.82190484 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82177336 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.81133045 |
| 99 | MP0008260_abnormal_autophagy | 0.79706270 |
| 100 | MP0009379_abnormal_foot_pigmentation | 0.78331833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Loss of speech (HP:0002371) | 3.49481418 |
| 2 | J-shaped sella turcica (HP:0002680) | 3.44989381 |
| 3 | Ragged-red muscle fibers (HP:0003200) | 3.44206160 |
| 4 | Dysostosis multiplex (HP:0000943) | 3.20981263 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.18270004 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 3.12835669 |
| 7 | Mucopolysacchariduria (HP:0008155) | 3.11908507 |
| 8 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.11908507 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.08592520 |
| 10 | Axonal loss (HP:0003447) | 3.02400903 |
| 11 | B lymphocytopenia (HP:0010976) | 3.00993116 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00338132 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00338132 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00338132 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.98102888 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.98102888 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.98102888 |
| 18 | Microvesicular hepatic steatosis (HP:0001414) | 2.88753203 |
| 19 | Abnormality of B cell number (HP:0010975) | 2.86758459 |
| 20 | Reduced antithrombin III activity (HP:0001976) | 2.82087193 |
| 21 | Thin bony cortex (HP:0002753) | 2.70110293 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.67796785 |
| 23 | Abnormal glycosylation (HP:0012345) | 2.67796785 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.67796785 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.67796785 |
| 26 | Sensorimotor neuropathy (HP:0007141) | 2.67381575 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 2.59780836 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 2.59330543 |
| 29 | Hyperparathyroidism (HP:0000843) | 2.58538924 |
| 30 | Progressive neurologic deterioration (HP:0002344) | 2.51255058 |
| 31 | Hypokinesia (HP:0002375) | 2.43128479 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.42845255 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41492941 |
| 34 | Deformed sella turcica (HP:0002681) | 2.41023424 |
| 35 | Breast carcinoma (HP:0003002) | 2.37245345 |
| 36 | Prostate neoplasm (HP:0100787) | 2.36982583 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35034501 |
| 38 | Increased muscle lipid content (HP:0009058) | 2.32709023 |
| 39 | Septate vagina (HP:0001153) | 2.31893312 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.31601487 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 2.31212209 |
| 42 | Sparse lateral eyebrow (HP:0005338) | 2.29642302 |
| 43 | Thrombocytosis (HP:0001894) | 2.29631954 |
| 44 | Hyperammonemia (HP:0001987) | 2.29065146 |
| 45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.27716676 |
| 46 | Abnormality of the thoracic spine (HP:0100711) | 2.27162200 |
| 47 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.21619856 |
| 48 | Villous atrophy (HP:0011473) | 2.21619856 |
| 49 | Renal Fanconi syndrome (HP:0001994) | 2.16542089 |
| 50 | Periodontitis (HP:0000704) | 2.11888349 |
| 51 | Prolonged neonatal jaundice (HP:0006579) | 2.10735609 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.08756557 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08221157 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.08221157 |
| 55 | Hyperalaninemia (HP:0003348) | 2.08221157 |
| 56 | Pancytopenia (HP:0001876) | 2.05657043 |
| 57 | Thoracic kyphosis (HP:0002942) | 2.03355702 |
| 58 | Neutropenia (HP:0001875) | 1.97438801 |
| 59 | Cardiomegaly (HP:0001640) | 1.96314446 |
| 60 | Abnormality of macrophages (HP:0004311) | 1.94278410 |
| 61 | Amelogenesis imperfecta (HP:0000705) | 1.94055329 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92591244 |
| 63 | Hypercortisolism (HP:0001578) | 1.92231612 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 1.91473894 |
| 65 | Multiple enchondromatosis (HP:0005701) | 1.89486127 |
| 66 | Abnormality of the costochondral junction (HP:0000919) | 1.89293565 |
| 67 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.87595504 |
| 68 | Eczematoid dermatitis (HP:0000976) | 1.85880017 |
| 69 | Increased IgM level (HP:0003496) | 1.85684282 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.85566466 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 1.85541505 |
| 72 | Abnormal trabecular bone morphology (HP:0100671) | 1.78906823 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78317441 |
| 74 | Neoplasm of the pancreas (HP:0002894) | 1.77124521 |
| 75 | Selective tooth agenesis (HP:0001592) | 1.74996247 |
| 76 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.73779296 |
| 77 | Abnormality of the prostate (HP:0008775) | 1.73638831 |
| 78 | Acute myeloid leukemia (HP:0004808) | 1.71967188 |
| 79 | Micronodular cirrhosis (HP:0001413) | 1.71518080 |
| 80 | Chromsome breakage (HP:0040012) | 1.70575175 |
| 81 | Elevated hepatic transaminases (HP:0002910) | 1.70405359 |
| 82 | Diaphragmatic weakness (HP:0009113) | 1.69812480 |
| 83 | Ketosis (HP:0001946) | 1.68669630 |
| 84 | Hypergammaglobulinemia (HP:0010702) | 1.67608536 |
| 85 | Premature loss of primary teeth (HP:0006323) | 1.67046935 |
| 86 | Bulbar palsy (HP:0001283) | 1.66879281 |
| 87 | Fasciculations (HP:0002380) | 1.66813787 |
| 88 | Testicular atrophy (HP:0000029) | 1.64710630 |
| 89 | Flat acetabular roof (HP:0003180) | 1.64497533 |
| 90 | Increased serum pyruvate (HP:0003542) | 1.64441945 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 1.64380465 |
| 92 | Cone-rod dystrophy (HP:0000548) | 1.63532538 |
| 93 | Bone pain (HP:0002653) | 1.63388740 |
| 94 | Abnormality of dental color (HP:0011073) | 1.61991065 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 1.60311518 |
| 96 | Progressive external ophthalmoplegia (HP:0000590) | 1.58042519 |
| 97 | Mediastinal lymphadenopathy (HP:0100721) | 1.57116988 |
| 98 | Petechiae (HP:0000967) | 1.56701790 |
| 99 | Rhabdomyolysis (HP:0003201) | 1.56655993 |
| 100 | Fatigue (HP:0012378) | 1.56370539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 3.99622869 |
| 2 | IRAK3 | 3.94766624 |
| 3 | TRIB3 | 3.50380708 |
| 4 | NME2 | 3.12598223 |
| 5 | MST4 | 2.75692642 |
| 6 | MAP3K12 | 2.21861615 |
| 7 | CDK19 | 2.19479361 |
| 8 | ACVR1B | 2.12903737 |
| 9 | SMG1 | 2.11910315 |
| 10 | BCKDK | 2.01375442 |
| 11 | TAOK2 | 1.88893394 |
| 12 | PRPF4B | 1.83757626 |
| 13 | RPS6KB2 | 1.79439729 |
| 14 | PBK | 1.76746368 |
| 15 | MAP3K11 | 1.76398086 |
| 16 | IRAK4 | 1.74519731 |
| 17 | MUSK | 1.72846254 |
| 18 | EIF2AK1 | 1.68574402 |
| 19 | ERN1 | 1.61417111 |
| 20 | SIK1 | 1.60202771 |
| 21 | ARAF | 1.57631953 |
| 22 | EIF2AK3 | 1.53647719 |
| 23 | TYK2 | 1.44272261 |
| 24 | IKBKE | 1.43104381 |
| 25 | BMPR2 | 1.31842722 |
| 26 | PIK3CA | 1.31024977 |
| 27 | PIM2 | 1.28950366 |
| 28 | LRRK2 | 1.25026107 |
| 29 | PRKCI | 1.19311838 |
| 30 | PRKD2 | 1.19261094 |
| 31 | STK16 | 1.18573646 |
| 32 | MAP2K3 | 1.17988581 |
| 33 | MAP3K5 | 1.17946239 |
| 34 | MAP3K1 | 1.15001431 |
| 35 | IRAK2 | 1.12886517 |
| 36 | DYRK1B | 1.10775516 |
| 37 | BLK | 1.09307396 |
| 38 | VRK2 | 1.09197953 |
| 39 | TESK2 | 1.07919921 |
| 40 | TBK1 | 1.06239248 |
| 41 | CDK6 | 0.97226940 |
| 42 | PKN2 | 0.93354052 |
| 43 | MATK | 0.90254860 |
| 44 | TESK1 | 0.87755000 |
| 45 | MAPK11 | 0.83731924 |
| 46 | BRAF | 0.82012903 |
| 47 | GRK6 | 0.81275575 |
| 48 | CDK7 | 0.80551045 |
| 49 | EEF2K | 0.79145733 |
| 50 | ATR | 0.77961939 |
| 51 | TTK | 0.76191165 |
| 52 | RIPK4 | 0.75372784 |
| 53 | TAOK1 | 0.75148500 |
| 54 | EPHA2 | 0.74969444 |
| 55 | ILK | 0.74634126 |
| 56 | JAK3 | 0.72121995 |
| 57 | MAPKAPK3 | 0.71326801 |
| 58 | MAP3K13 | 0.70566729 |
| 59 | DMPK | 0.67276031 |
| 60 | STK4 | 0.66814978 |
| 61 | MAP3K3 | 0.65641176 |
| 62 | MAP3K2 | 0.64056887 |
| 63 | DYRK3 | 0.62366624 |
| 64 | PLK1 | 0.61948123 |
| 65 | AURKA | 0.61724521 |
| 66 | CDK4 | 0.61600338 |
| 67 | PAK4 | 0.61058231 |
| 68 | DAPK1 | 0.60779082 |
| 69 | ICK | 0.60675800 |
| 70 | AURKB | 0.59727832 |
| 71 | MAP3K8 | 0.59309092 |
| 72 | RAF1 | 0.57527184 |
| 73 | HIPK2 | 0.55034485 |
| 74 | MAP3K14 | 0.53832937 |
| 75 | AKT2 | 0.52290501 |
| 76 | MAP3K9 | 0.52079658 |
| 77 | PDPK1 | 0.49872343 |
| 78 | CSK | 0.49845925 |
| 79 | ALK | 0.49477335 |
| 80 | PRKG2 | 0.49352204 |
| 81 | CCNB1 | 0.48142962 |
| 82 | IRAK1 | 0.47036805 |
| 83 | CSF1R | 0.46796613 |
| 84 | MELK | 0.45578863 |
| 85 | MTOR | 0.44519550 |
| 86 | PIM1 | 0.43871411 |
| 87 | EPHB1 | 0.43627495 |
| 88 | KSR2 | 0.42015457 |
| 89 | IKBKB | 0.41931083 |
| 90 | NUAK1 | 0.41501177 |
| 91 | STK39 | 0.40958327 |
| 92 | PAK1 | 0.38475623 |
| 93 | RPS6KL1 | 0.37693094 |
| 94 | RPS6KC1 | 0.37693094 |
| 95 | CHUK | 0.36386857 |
| 96 | MAP2K2 | 0.35427169 |
| 97 | RPS6KA4 | 0.34208780 |
| 98 | CHEK2 | 0.34021909 |
| 99 | ZAK | 0.33710832 |
| 100 | TNK2 | 0.33677228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.03171471 |
| 2 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.79110803 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.77371086 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.62720389 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.46322125 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.01899265 |
| 7 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.90037331 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 1.88136811 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76991435 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.73206837 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64468168 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.62635692 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 1.61393389 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48595709 |
| 15 | Hepatitis C_Homo sapiens_hsa05160 | 1.46887628 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46597132 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42127616 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42119874 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36652387 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.32796932 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31509103 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30727485 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27826661 |
| 24 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25209091 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24193723 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18661340 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.16882228 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16186251 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15558119 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15389993 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.13089127 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10884083 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08696038 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08582553 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07483812 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07348484 |
| 37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06990334 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04749755 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.01636398 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01129959 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97313262 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96544476 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94589754 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 0.94329680 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91926442 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91166261 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89479306 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 0.88765080 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.88272230 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.88234367 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.83946495 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83575760 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.82379100 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.81113278 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.80344720 |
| 56 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80227862 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.79627226 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76179002 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75999172 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75801272 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75469441 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.72344118 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71102247 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70117531 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.69840221 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69600878 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69338433 |
| 68 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69010899 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68630898 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67675145 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67575393 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67489233 |
| 73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67110220 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.66434485 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63295698 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61893907 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61316764 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57004900 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56663756 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55539563 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55188917 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.54653260 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54230453 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54004975 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52399190 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.52259129 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51676971 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51465428 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51398194 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.51045256 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50665161 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.49702826 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48519040 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48510814 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.48004266 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47203407 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46580814 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44123009 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42539281 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41697213 |

